EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Epidemiology, clinical characteristics, and outcomes for heart failure with improved ejection fraction by chronological age

Kishan Srikanth iD, Keane Lee, Alan S Go, Rishi V Parikh, Andrew P Ambrosy, Thida C Tan, Kyung Min, Steven A Hamilton, Jana Svetlichnaya, Scott D Solomon iD, Muthiah Vaduganathan iD, Riccardo M Inciardi und 6 weitere

ESC Heart Failure · 04.07.2026 · 13 (4)

DOI: 10.1093/eschf/xvag158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 29.07.2026. Verfasst von Kishan Srikanth und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Kaiser Permanente SanFrancisco Medical Center, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Ventricular Function, Left. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims HF incidence increases with age. Novel treatments have led to more patients recovering LVEF, now classified as HF with improved ejection fraction (HFimpEF). However, the age-related epidemiology and prognosis of HFimpEF remain unclear. Methods and Results We identified adults ≥18 years with incident HFrEF (LVEF ≤40%) between 2013 and 2022 within Kaiser Permanente Northern California (KPNC), a healthcare delivery system serving 4.5 million members. HFimpEF was defined as baseline LVEF ≤40% with improvement to ≥40%. HFimpEF incidence was assessed by baseline age categories (<50, 50–64, 65–79, ≥80 years [yrs]). Rates of worsening HF (WHF) events (i.e. HF-related hospitalization, ED, or outpatient visits) were compared between HFimpEF and persistent HFrEF patients across age using Cox proportional hazards models adjusted for sex, race, and EF at the time of incident HFrEF, including evaluation of a potential interaction by age. Data Among 28 292 adults with incident HFrEF, 35% experienced HFimpEF, with lower rates at older ages: 43% (<50 yrs), 42% (50–64 yrs), 39% (65–79 yrs), and 21% (≥80 yrs) (P < .001 for trend). WHF incidence rates (per 100 person-years) increased with age: 10.6 [95% CI, 9.5–11.7] (<50 yrs), 14.5 [13.7–15.3] (50–64 yrs), 20.8 [20.0–21.6] (65–79 yrs), and 31.7 [29.9–33.5] (≥80 yrs). Patients with HFimpEF, compared to those with persistent HFrEF, had lower adjusted rates of WHF, a finding more prominent at lower ages (pinteraction by age <0.001). Conclusions HFimpEF is common within a year of incident HFrEF, more prevalent in younger patients, and is associated with continued residual risk. Compared to persistent HFrEF, improvements in LVEF are associated with lower risk of WHF or death across the age spectrum. Additional research is needed to understand HF symptom burden and medical therapy use in this population to inform shared decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumeVentricular Function, LeftHumansFemaleIncidenceMaleAgedCaliforniaMiddle AgedPrognosisAge FactorsAged, 80 and overRetrospective StudiesFollow-Up Studies

Stichwörter der Autor:innen

Cardiovascular diseaseEjection fractionGDMT (guideline-directed medical therapy)Heart failure

Autor:innen und Institutionen

  • Department of Medicine, Kaiser Permanente SanFrancisco Medical Center, San Francisco, CA, USA.
  • Department of Cardiology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA, USA.
  • Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA.
  • Department of Epidemiology and Population Health Stanford University, Palo Alto, CA, USA.
  • Department of Cardiology, Kaiser Permanente SanFrancisco Medical Center, San Francisco, CA 94115, USA.
  • Department of Cardiology, Brigham and Women's Hospital, Boston, MA 02115, USA.

ORCID-Profile: Kishan Srikanth, Scott D Solomon, Muthiah Vaduganathan, Orly Vardeny, Ankeet S Bhatt

Zitieren

APA

Srikanth, K., Lee, K., Go, A. S., Parikh, R. V., Ambrosy, A. P., Tan, T. C., Min, K., Hamilton, S. A., Svetlichnaya, J., Solomon, S. D., Vaduganathan, M., Inciardi, R. M., Vardeny, O., Vasti, E., Sandhu, A. T., Ku, I. A., Adatya, S., & Bhatt, A. S. (2026). Epidemiology, clinical characteristics, and outcomes for heart failure with improved ejection fraction by chronological age. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag158

Vancouver

Srikanth K, Lee K, Go AS, Parikh RV, Ambrosy AP, Tan TC, et al. Epidemiology, clinical characteristics, and outcomes for heart failure with improved ejection fraction by chronological age. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag158

BibTeX
@article{Srikanth2026,
  author = {Srikanth, Kishan and Lee, Keane and Go, Alan S and Parikh, Rishi V and Ambrosy, Andrew P and Tan, Thida C and Min, Kyung and Hamilton, Steven A and Svetlichnaya, Jana and Solomon, Scott D and Vaduganathan, Muthiah and Inciardi, Riccardo M and Vardeny, Orly and Vasti, Elena and Sandhu, Alexander T and Ku, Ivy A and Adatya, Sirtaz and Bhatt, Ankeet S},
  title = {Epidemiology, clinical characteristics, and outcomes for heart failure with improved ejection fraction by chronological age},
  journal = {ESC Heart Failure},
  year = {2026},
  volume = {13},
  number = {4},
  doi = {10.1093/eschf/xvag158}
}
Kostenlos starten →